Nasdaq DW Global Momentum Q3 2020 commentary

Nasdaq DW Global Momentum Q3 2020 commentary

SaxoSelect Commentaries
Saxo Markets

Instruments traded
Stocks
Asset classesGlobal equities (including emerging markets, excluding US companies)
Investment styleSystematic investing based on stocks’ relative strength
Quarterly return3.96% (net of fees)
Annualised volatility (since inception)21.5%

Market overview

The global economies and global markets continued their recovery in the third quarter which was a strong quarter across the board. It has been a wild ride in stock markets this year with elevated volatility along with strong returns. The U.S. Dollar fell during the quarter, and that gave international equities a relative strength for the first time in a long while. Emerging markets (MSCI Emerging Markets TR) led the way higher finishing up 9.7%. Developed markets (MSCI EAFE TR) didn’t fare as well finishing up only 4.8%.  

The global economy has begun to rebound from dramatic losses brought on earlier in the year when strict stay-at-home orders in many parts of the world caused the economy to contract rapidly. A lot will depend on countries around the globe having the ability to keep opening economies back up while still maintaining acceptable virus infection levels. Any speculation on how this will go is very difficult because we have never seen anything like this in modern history. The Nasdaq Dorsey Wright portfolio management team (the “Team”) is anticipating added volatility as the situation plays out, and the Team may need to make portfolio changes if things reverse course.

There was talk near the end of the quarter that value-stocks (attractively priced stocks) may start to re-assert itself versus growth-stocks (stocks priced for substantial future growth). The Team thinks it is premature to make that call. Growth-stocks dramatically outperformed during the quarter, which is just an extension of a multi-year trend.  There have been small pullbacks along the way where value has outperformed growth.  In each of those cases, growth has resumed leadership and pushed to new highs.  Until the Team sees Growth unable to resume leadership and break critical support levels versus Value, the Team remains committed to the dominant Growth theme.  

Portfolio performance

Jul6.52%
Aug
-0.54%
Sep
-1.86%
Since inception (March 2006*)
239.6%

Performance is net of all fees
* Performance prior to Nov 2017 occurred before the partnership with Saxo Bank A/S

Top 10 portfolio holdings (as of 30/09/20)
44.9%of total portfolio

DescriptionSymbol  % Mkt val
MERCADOUBRE INC COM
 MEU 6.5
NICE LTD ADR SPONSORED
 NICE 6.26
ARGENX SE ADR SPONSORED
 ARGX 5.98
GOLD FIELDS LTD ADR SPONSOREDGFI 5.63
TAL EDUCATION GROUP ADR
 TAL 4.05
 ANGLOGOLD ASHANTI LTD ADR SPONSOREDAU 3.7
 ASML HOLDING NV ADR SPONSOREDASML 3.51
 ICON PLC COMICLR 3.16
 ZTO EXPRESS (CAYMAN) INC ADR SPONSORED ZTO 3.13
 SIBANYE STILLWATER LTD ADR SPONSORED SBSW 3.03

Best performing positions

  • Gold Fields Limited operates as a gold producer with reserves and resources in Chile, South Africa, Ghana, Australia, and Peru. It holds interests in nine operating mines with an annual gold-equivalent production of approximately 2.2 million ounces, as well as gold mineral reserves of approximately 51.3 million ounces and mineral resources of approximately 115.7 million ounces. The company also holds copper mineral reserves and mineral resources. Gold Fields Limited was founded in 1887 and is based in Sandton, South Africa.

  • NICE Ltd. provides enterprise software solutions worldwide. The company operates in two segments, Customer Engagement, and Financial Crime and Compliance. NICE Ltd. was founded in 1986 and is based in Ra'anana, Israel.

  • Argenx SE, a clinical-stage biotechnology company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases, hematology, and cancer. argenx SE was founded in 2008 and is based in Breda, the Netherlands.

  • Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. The company was founded in 1984 and is headquartered in Hyderabad, India.

  • Sibanye Stillwater Limited operates as a precious metals mining company in South Africa, the United States, Zimbabwe, Canada, and ArgentinaSibanye Gold Limited was incorporated in 2002 and is headquartered in Weltevreden Park, South Africa.

Worst performing positions

  • Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium.

  • ZTO Express Inc. provides express delivery and other value-added logistics services in the People's Republic of China. The company offers delivery services for e-commerce and traditional merchants, and other express service users. As of December 31, 2019, it operated a fleet of approximately 6,450 self-owned trucks. The company was founded in 2002 and is headquartered in Shanghai, the People's Republic of China.
     
  • Vipshop Holdings Limited operates as an online discount retailer for various brands in the People's Republic of China. The company was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

  • AngloGold Ashanti Limited operates as a gold mining company. It also produces gold, silver, uranium, and sulphuric acid; and dóre bars. The company operates 14 mines and three projects in nine countries in South Africa, Continental Africa, the Americas, and Australia. AngloGold Ashanti Limited was incorporated in 1944 and is headquartered in Johannesburg, South Africa.

  • CRH plc, through its subsidiaries, manufactures and distributes building materials. It serves governments, contractors, homebuilders, homeowners, and sub-contractors. The company operates primarily in the Republic of Ireland, the United Kingdom, the rest of Europe, the United States, and internationally. CRH plc was founded in 1936 and is headquartered in Dublin, Ireland.

Outlook 

It has been a challenging year dealing with the global pandemic, but investment returns have been solid – especially momentum. The spread of COVID has caused a great deal of uncertainly. The Team’s process is not designed to guess what is going to happen.  The Team will wait for any trends to develop and position the portfolios accordingly.  

As the Team looks forward to the rest of the year, the Team believes there will be many opportunities for the strategy to capitalize.  

Disclaimer

This material is provided for marketing and/or information purposes only. Fee charges mentioned herein are subject to change – you may find the latest updated pricing information on the description page for the respective portfolios. None of the information contained herein constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. Saxo Capital Markets does not take into account your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and commentaries are not intended to be and do not constitute financial advice, investment advice, trading advice or any other advice or recommendation of any sort offered or endorsed by Saxo Capital Markets. Any expression of opinion (which may be subject to change without notice) is personal to the author and the author makes no guarantee of any sort regarding accuracy or completeness of any information or analysis supplied. Although every endeavour has been made to ensure that our trading platforms are secure and reliable, please note that as with all facilities and systems, our trading platforms may be vulnerable to temporary disruption or failure. If you undertake transactions on an electronic trading system, you will be exposed to risks associated with systemic failure, i.e. failure of hardware and software.  

See the full Managed Portfolio Disclaimer for more information. Please also consider our Risk Warning and General Business Terms before trading with us.

Saxo Markets
Most of our staff in Singapore are working from home to help limit the spread of the coronavirus. We remain at your service on the details below. Thank you for your understanding.

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.